Pediatric-onset multiple sclerosis in African-American black and European-origin white patients

Aaron L Boster1, Christina F Endress, Stephanie A Hreha

  • 1Department of Neurology, The Ohio State University, Columbus, Ohio, USA.

Pediatric Neurology
|December 11, 2008
PubMed

Insights

Pediatric multiple sclerosis (MS) shows a more aggressive disease course in African-American children compared to European-origin children. African-American children experienced higher relapse rates, indicating a need for further research.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Pediatric-onset multiple sclerosis (MS) is increasingly recognized.
  • The relationship between ethnicity and pediatric MS disease characteristics is understudied.

Purpose of the Study:

  • To investigate ethnic differences in the clinical presentation and disease course of pediatric-onset MS.
  • To compare disease characteristics between African-American and European-origin children diagnosed with MS.

Main Methods:

  • Retrospective review of 46 patients with pediatric-onset MS at a major teaching facility.
  • Comparison of demographic and clinical data between African-American (n=24) and European-origin (n=19) patients.
  • Analysis included age at onset, follow-up duration, time to disease-modifying therapy, sex distribution, and annualized relapse rate.

Main Results:

  • No significant differences in mean age at onset or follow-up duration between ethnic groups.
  • A significantly higher percentage of females in the African-American group (83%) compared to the European-origin group (47%).
  • The annualized relapse rate was significantly higher in African-American children (1.80) versus European-origin children (1.13).

Conclusions:

  • Findings suggest a more aggressive disease phenotype in African-American children with pediatric-onset MS.
  • Results align with observations in adult-onset MS, indicating a potential pattern across age groups.
  • Larger multicenter studies are recommended to validate these ethnic-based findings in pediatric MS.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...